8.21MMarket Cap
LossP/E TTM
Bolt Biotherapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-26The current valuation score of Bolt Biotherapeutics Inc is 9.01, ranking 66 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.26, which is -97.08% below the recent high of -0.01 and -245.91% above the recent low of -0.90.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.